|
2010 Journal Article Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases PharmacistsMartin, Jennifer H., Norris, Ross, Barras, Michael, Roberts, Jason, Morris, Ray, Doogue, Matthew and Jones, Graham R. D. (2010). Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Clinical Biochemist Reviews, 31 (1), 21-24. |
|
2010 Journal Article Routine plasma anti-Xa monitoring is required for low-molecular-weight heparinsAl-Sallami, Hesham S., Barras, Michael A., Green, Bruce and Duffull, Stephen B. (2010). Routine plasma anti-Xa monitoring is required for low-molecular-weight heparins. Clinical Pharmacokinetics, 49 (9), 567-571. doi: 10.2165/11532960-000000000-00000 |
|
2009 Other Outputs Dose individualisation of enoxaparinMichael Barras (2009). Dose individualisation of enoxaparin. PhD Thesis, Pharmacy school, The University of Queensland. |
|
2009 Conference Publication The impact of an individualised medication information session on medication knowledge and quality of life of people with parkinson’s diseaseO’Maley, Karen A., O’Sullivan, John D., Wollin, Judy and Barras, Michael (2009). The impact of an individualised medication information session on medication knowledge and quality of life of people with parkinson’s disease. Australian and New Zealand Association of Neurologists (ANZAN) 2008 Annual Scientific Meeting, Australia, 2008. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jocn.2008.07.043 |
|
2009 Journal Article Myalgia in patients on high-dose and low-to-moderate dose statin therapyGujral, Gina R., Cottrell, W. Neil and Barras, Michael (2009). Myalgia in patients on high-dose and low-to-moderate dose statin therapy. Journal of Pharmacy Practice and Research, 39 (3), 202-206. doi: 10.1002/j.2055-2335.2009.tb00453.x |
|
2009 Book Chapter Dose individualization of drugs based on body compositionBarras, Michael and Green, Bruce (2009). Dose individualization of drugs based on body composition. Heart disease in men. (pp. 219-242) edited by Alice B. Todd and Margo H. Mosley. New York, NY, United States: Nova Science Publishers. |
|
2009 Journal Article Modelling the occurrence and severity of enoxaparin-induced bleeding and bruising eventsBarras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2009). Modelling the occurrence and severity of enoxaparin-induced bleeding and bruising events. British Journal of Clinical Pharmacology, 68 (5), 700-711. doi: 10.1111/j.1365-2125.2009.03518.x |
|
2009 Journal Article Preliminary results of a therapeutic drug monitoring survey in AustralasiaNorris, R. L., Morris, R. G., Ray, J. E., Fullinfaw, R. O., Ilett, K. F., Lee, T., Martin, J., Barras, M., Thompson, E. M. and Jones, G. R. D. (2009). Preliminary results of a therapeutic drug monitoring survey in Australasia. Pathology, 41 (s1), 71-71. doi: 10.1097/01268031-200941001-00167 |
|
2009 Conference Publication A survey of therapeutic drug monitoring in AustralasiaNorris, Ross, Morris, Ray, Thompson, Erin, Ray, John, Barras, Michael, Jones, Graham and Martin, Jenny (2009). A survey of therapeutic drug monitoring in Australasia. 11th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Montréal, QC, Canada, 3-8 October 2009. New York, NY, U.S.A.: Lippincott-Raven. doi: 10.1097/FTD.0b013e3181b7997b |
|
2008 Journal Article Individualized compared with conventional dosing of enoxaparinBarras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2008). Individualized compared with conventional dosing of enoxaparin. Clinical Pharmacology & Therapeutics, 83 (6), 882-888. doi: 10.1038/sj.clpt.6100399 |
|
2008 Journal Article Individualised vs conventional enoxaparin dosingBarras, Michael A. and Green, Bruce (2008). Individualised vs conventional enoxaparin dosing. Journal of Pharmacy Practice and Research, 38 (1), 77-81. doi: 10.1002/j.2055-2335.2008.tb00803.x |
|
2008 Conference Publication The evaluation of an individualised dosing strategy derived from population PK modelling and simulationBarras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2008). The evaluation of an individualised dosing strategy derived from population PK modelling and simulation. Population Approach Group in Australia and New Zealand (PAGANZ) Conference, Dunedin, Otago, New Zealand, 13-15 February 2008. |
|
2008 Conference Publication The evaluation of an individualised dosing strategy for enoxaparinBarras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2008). The evaluation of an individualised dosing strategy for enoxaparin. The 34th Society of Hospital Pharmacists of Australia (SHPA) National Conference, Adelaide Australia, September 2008. |
|
2008 Conference Publication A survey of therapeutic drug monitoring in Australia and New ZealandNorris, R., Morris, R., Ray, J., Ilett, K.F., Fullinfaw, R., Lee, T., Martin, J., Barras, M., Thompson, E. M. and Jones, G. R. D. (2008). A survey of therapeutic drug monitoring in Australia and New Zealand. Australasian Association of Clinical Biochemists’ 45th Annual Scientific Conference, Adelaide, South Australia, 16-19 September 2008. Mt. Lawley, W.A., Australia: Australasian Association of Clinical Biochemists. |
|
2008 Conference Publication Individualized compared with conventional dosing of enoxaparinBarras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2008). Individualized compared with conventional dosing of enoxaparin. Population Approach Group in Europe (PAGE) Conference, Marseille, France, June 2008. Leiden: Population Approach Group in Europe. |
|
2007 Journal Article Maximal torque- and power-pedaling rate relationships for elite sprint cyclists in laboratory and field testsGardner, A. Scott, Martin, James C., Martin, David T., Barras, Martin and Jenkins, 47517 (2007). Maximal torque- and power-pedaling rate relationships for elite sprint cyclists in laboratory and field tests. European Journal of Applied Physiology, 101 (3), 287-292. doi: 10.1007/s00421-007-0498-4 |
|
2007 Journal Article General practitioner referral letters: are we getting the full picture?Toleman, J. and Barras, M. (2007). General practitioner referral letters: are we getting the full picture?. Internal Medicine Journal, 37 (7), 510-511. doi: 10.1111/j.1445-5994.2007.01416.x |
|
2007 Conference Publication Comparison of self reported myalgia in individuals on high and low to moderate dose statin therapyGujral, G., Barras, M. and Cottrell, W. N. (2007). Comparison of self reported myalgia in individuals on high and low to moderate dose statin therapy. Medicines: Design to Delivery. Manly 2007 2nd Annual Conference of The Australasian Pharmaceutical Science Association, Manly, NSW, Australia, 8-11 December 2007. Australian Pharmaceutical Science Association (APSA). |
|
2007 Journal Article Pharmacists investigating adverse penicillin responses - Pilot StudyRoberts, Jason A., Hsu, Millie, Allen, Karen, Willis, Jennifer and Barras, Michael (2007). Pharmacists investigating adverse penicillin responses - Pilot Study. Journal of Pharmacy Practice and Research, 37 (3), 200-203. doi: 10.1002/j.2055-2335.2007.tb00744.x |
|
2007 Conference Publication A Population PKPD Model for Bleeding Events with EnoxaparinBarras, M. A., Duffull, S., Atherton, J. and Green, B. (2007). A Population PKPD Model for Bleeding Events with Enoxaparin. 2007 AAPS Annual Meeting and Exposition, San Diego California, 11th-15th November, 2007. |
